1cBio, Inc.
PrivateCompany Overview
1cBio, Inc. is a biotechnology company that develops precision medicines for cancer and rare diseases using expertise in medicinal chemistry and translational sciences.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
1cBio, Inc. Comparables
Compare 1cBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duke Street Bio | 86% | |
| Acerand Therapeutics | 82% | |
| Synnovation Therapeutics | 81% | |
1cBio, Inc. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2025
Monthly visitors increased 31% MoM, reaching 1.3K.
- Mar 22, 2024
Grew 30% QoQ from 10 to 13 employees.
1cBio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 1cBio, Inc.'s valuation, stock price, and market status.